Capsensixx AG (FRA:CPX) Total Stockholders Equity: €15.7 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CPX Capsensixx AG FRA:CPX
93 GF Score
Price €21.00
GF Value €27.92
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Capsensixx AG Total Stockholders Equity?

Capsensixx AG FRA:CPX 93 Total Stockholders Equity is €15.7 Mil as of Dec. 2025. GuruFocus rates FRA:CPX with a GF Score™ of 93/100 and a GF Value™ of €27.92 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Capsensixx AG's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €15.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Capsensixx AG's Book Value per Share for the quarter that ended in Dec. 2025 was €5.85. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Capsensixx AG's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.28.


Capsensixx AG  (FRA:CPX) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Capsensixx AG's Book Value per Share for the quarter that ended in Dec. 2025 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Capsensixx AG's Debt-to-Equity for the quarter that ended in Dec. 2025 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Capsensixx AG Total Stockholders Equity Related Terms


Capsensixx AG Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Capsensixx AG's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Capsensixx AG Total Stockholders Equity Chart

Capsensixx AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.04 14.88 16.37 16.79 15.72

Capsensixx AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.37 17.79 16.79 18.27 15.72
FRA:CPX
93GF Score
Capsensixx AG FRA:CPX
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €15.7 Mil mean?
Capsensixx AG (FRA:CPX) has a Total Stockholders Equity of €15.7 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Capsensixx AG and its competitors.
Is Capsensixx AG's Total Stockholders Equity too high?
Capsensixx AG's current Total Stockholders Equity is €15.7 Mil. Overall, Capsensixx AG has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Capsensixx AG's Total Stockholders Equity compare to BLK and BX?
Capsensixx AG's Total Stockholders Equity of €15.7 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for an Asset Management company?
A good Total Stockholders Equity depends on the Asset Management industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Capsensixx AG and its competitors. Capsensixx AG's current Total Stockholders Equity is €15.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Capsensixx AG stock overvalued right now?
Based on GuruFocus' analysis, Capsensixx AG (FRA:CPX) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.92, compared to a current price of €21.00 — trading 24.8% below its estimated fair value. The current Total Stockholders Equity is €15.7 Mil. Capsensixx AG's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Capsensixx AG (FRA:CPX), the current Total Stockholders Equity is €15.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Capsensixx AG (FRA:CPX) Overvalued in 2026?

Based on GuruFocus' analysis, Capsensixx AG stock appears to be undervalued. The current stock price of €21.00 is trading 24.8% below its estimated GF Value™ of €27.92. GuruFocus considers Capsensixx AG to be Modestly Undervalued.

Key valuation signals for FRA:CPX:

  • Total Stockholders Equity: €15.7 Mil
  • GF Value™: €27.92 vs. price of €21.00 (24.8% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the FRA:CPX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Capsensixx AG Business Description

Other Exchanges CPX:Germany
Address Bettinastrasse 57-59, Frankfurt, DEU, D-60325
Capsensixx AG is a provider of financial administration as a service. The company is divided into two segments namely Funds management, Administration and Accounting Segment which includes fund management and fund accounting; and Securitisations which provides Advisory services in the field of financial engineering, securitisation and provision of director and administrative services to corporate clients in Luxembourg.
93GF Score

Get the complete analysis for FRA:CPX

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€21.00
Price
€27.92
GF Value